Although flu infections are not yet swamping the system, health officials report a noticeable uptick in cases that began in early December and continues to escalate.
Doctors who treat COVID-19 patients in the Twin Cities are voicing optimism over Pfizer's antiviral pill, known as Paxlovid. Pfizer released new data from its clinical trials of Paxlovid Tuesday, showing the pill significantly reduced the risk of hospitalization and death.
Doctors who treat COVID-19 patients in the Twin Cities are voicing optimism over Pfizer's antiviral pill, known as Paxlovid. Pfizer released new data from its clinical trials of Paxlovid Tuesday, showing the pill significantly reduced the risk of hospitalization and death.